Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

RNasin® Ribonuclease Inhibitors: Superior Performance for All of Your RNA Analysis Needs

Kyle Hooper
Promega Corporation
Publication Date: 2004

Abstract

Over 6,000 papers have cited RNasin® Ribonuclease Inhibitors as the source of RNase protection since Promega introduced RNasin® Inhibitors in 1982, making them the most trusted reagents for RNA protection. RNasin® Inhibitors work by binding strongly to RNases, preventing them from degrading vulnerable RNA molecules during manipulation in the laboratory. RNase inhibitors work in a variety of experimental situations and conditions. Reliable RNase inhibitors satisfy three major criteria. This article presents these criteria and shows that RNasin® Ribonuclease Inhibitors fulfill them, ensuring that RNases will not interfere with your RNA analysis work.

Promega Notes 86, 25–27.